Next Article in Journal
Dysregulation of Mitochondrial Homeostasis in Cardiovascular Diseases
Previous Article in Journal
Syringaldehyde Alleviates Cardiac Hypertrophy Induced by Hyperglycemia in H9c2 Cells Through GLP-1 Receptor Signals
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceuticals
Volume 18
Issue 1
10.3390/ph18010111
pharmaceuticals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Pharmaceuticals 2021, 14(6), 515.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Khavinson et al. Neuroprotective Effects of Tripeptides—Epigenetic Regulators in Mouse Model of Alzheimer’s Disease. Pharmaceuticals 2021, 14, 515

by
Vladimir Khavinson
1,2,
Anastasiia Ilina
1,*,
Nina Kraskovskaya
3,
Natalia Linkova
1,
Nina Kolchina
4,5,
Ekaterina Mironova
1,
Alexander Erofeev
3 and
Michael Petukhov
4,5
1
Saint Petersburg Institute of Bioregulation and Gerontology, 197110 Saint Petersburg, Russia
2
Pavlov Institute of Physiology of Russian Academy of Sciences, 199034 Saint Petersburg, Russia
3
Institute of Biomedical Systems and Biotechnology, Peter the Great St. Petersburg State Polytechnic University, 195251 Saint Petersburg, Russia
4
Petersburg Nuclear Physics Institute Named after B.P. Konstantinov, NRC “Kurchatov Institute”, 188300 Gatchina, Russia
5
Russian Scientific Center of Radiology and Surgical Technologies Named after A.M. Granov, 197758 Saint Petersburg, Russia
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2025, 18(1), 111; https://doi.org/10.3390/ph18010111
Submission received: 16 December 2024 / Accepted: 26 December 2024 / Published: 16 January 2025
(This article belongs to the Section Medicinal Chemistry)
Browse Figures
Versions Notes
In the original publication [1], there was a mistake in Figures 5 and 8 as published. The mistake is that Figures 5 and 8 are the same, described differently. The corrected Figure 5 and Figure 8 appear below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Khavinson, V.; Ilina, A.; Kraskovskaya, N.; Linkova, N.; Kolchina, N.; Mironova, E.; Erofeev, A.; Petukhov, M. Neuroprotective Effects of Tripeptides—Epigenetic Regulators in Mouse Model of Alzheimer’s Disease. Pharmaceuticals 2021, 14, 515. [Google Scholar] [CrossRef] [PubMed]
Pharmaceuticals 18 00111 g005
Figure 5. Confocal images of the CA1 secondary dendrites in 5 month-old male M-line (a) and 5xFAD-M mice, injected with a physiological solution (b), EDR peptide (c), KED peptide (d). Confocal microscopy, ×100. Scale bar, 10 μm.
Figure 5. Confocal images of the CA1 secondary dendrites in 5 month-old male M-line (a) and 5xFAD-M mice, injected with a physiological solution (b), EDR peptide (c), KED peptide (d). Confocal microscopy, ×100. Scale bar, 10 μm.
Pharmaceuticals 18 00111 g005
Pharmaceuticals 18 00111 g008
Figure 8. Confocal images of the CA1 secondary dendrites in 5 month-old female M (a) end 5xFAD-M mice injected with a physiological solution (b), EDR peptide (c), KED peptide (d). Confocal microscopy, ×100. Scale bar, 10 μm.
Figure 8. Confocal images of the CA1 secondary dendrites in 5 month-old female M (a) end 5xFAD-M mice injected with a physiological solution (b), EDR peptide (c), KED peptide (d). Confocal microscopy, ×100. Scale bar, 10 μm.
Pharmaceuticals 18 00111 g008
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Khavinson, V.; Ilina, A.; Kraskovskaya, N.; Linkova, N.; Kolchina, N.; Mironova, E.; Erofeev, A.; Petukhov, M. Correction: Khavinson et al. Neuroprotective Effects of Tripeptides—Epigenetic Regulators in Mouse Model of Alzheimer’s Disease. Pharmaceuticals 2021, 14, 515. Pharmaceuticals 2025, 18, 111. https://doi.org/10.3390/ph18010111

AMA Style

Khavinson V, Ilina A, Kraskovskaya N, Linkova N, Kolchina N, Mironova E, Erofeev A, Petukhov M. Correction: Khavinson et al. Neuroprotective Effects of Tripeptides—Epigenetic Regulators in Mouse Model of Alzheimer’s Disease. Pharmaceuticals 2021, 14, 515. Pharmaceuticals. 2025; 18(1):111. https://doi.org/10.3390/ph18010111

Chicago/Turabian Style

Khavinson, Vladimir, Anastasiia Ilina, Nina Kraskovskaya, Natalia Linkova, Nina Kolchina, Ekaterina Mironova, Alexander Erofeev, and Michael Petukhov. 2025. "Correction: Khavinson et al. Neuroprotective Effects of Tripeptides—Epigenetic Regulators in Mouse Model of Alzheimer’s Disease. Pharmaceuticals 2021, 14, 515" Pharmaceuticals 18, no. 1: 111. https://doi.org/10.3390/ph18010111

APA Style

Khavinson, V., Ilina, A., Kraskovskaya, N., Linkova, N., Kolchina, N., Mironova, E., Erofeev, A., & Petukhov, M. (2025). Correction: Khavinson et al. Neuroprotective Effects of Tripeptides—Epigenetic Regulators in Mouse Model of Alzheimer’s Disease. Pharmaceuticals 2021, 14, 515. Pharmaceuticals, 18(1), 111. https://doi.org/10.3390/ph18010111

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop